Epidemiology
Main content
Background and aims
These projects aims to further advance the knowledge about the incidence, distribution and possible risk factors relating to multiple sclerosis.
Ongoing projects
Survival in MS in the Nordics.
Time frame: 2020 - 2023
Cooperation with:
Please contact: Nina Grytten (postdoktor)
E-mail: nina.grytten@helse-bergen.no
Phone: +47 55 97 55 03
Norwegian Multiple Sclerosis Competence Centre
Dept. of Neurology
Haukeland University Hospital
5021 Bergen
OR
Stig Wergeland
E-mail: stig.wergeland@helse-bergen.no
Why do patients with multiple sclerosis (MS) die young? Comorbidity and predictors of long-term survival in MS
Our objective is to increase the understanding of comorbid diseases and the reason for premature death in multiple sclerosis (MS), by using epidemiological methods. The study is a population- based registry cohort with data from Norwegian MS registry and Biobank, Norwegian Cancer Registry, Cause of Death Registry, Population Registry and Norwegian Educational Database.A growing amount of evidence indicates that comorbidity has major impact on MS patients’ disease burden, disability progression, survival, and health care utilization, which are consequential for patients, their caregivers and society. Time frame for the project is until 2021.
Please contact: Nina Grytten Torkildsen (postdoctor)
E-mail: nina.grytten@helse-bergen.no
Phone: +47 55 97 55 03
Norwegian Multiple Sclerosis Competence Centre
Dept. of Neurology
Haukeland University Hospital
5021 Bergen
Cancer risk in multiple sclerosis patients, parents, and healthy controls: a prospective, longitudinal cohort study
The objective was to prospectively investigate cancer risk in multiple sclerosis (MS) by comparing MS patients to siblings without MS and to non- MS population controls. Data on MS patients born between 1930 and 1979 were retrieved from the Norwegian MS Registry and prevalence studies from Norway, cancer from the Norwegian Cancer Registry, and education from the Norwegian Educational Registry. Patients were linked to siblings by personal identification number by Norwegian Population Registry. Cox proportional hazard regression, adjusted for age, gender, residence and education was used to estimate cancer risk among 6935 MS patients, 9346 siblings without MS and 38055 non-MS controls. Cancer has consequences on MS patients premature death, and the disclosure of risk of cancer among MS patients is important to increase survival.Time frame: 2023
Please contact: Nina Grytten Torkildsen (postdoctor)
E-mail: nina.grytten@helse-bergen.no
Tel: +47 55975503
Norwegian Multiple Sclerosis Competence Centre
Dept. of Neurology
Haukeland University Hospital
5021 Bergen
Mor og Barn studien (risikofaktorer for MS)
More information coming soon.
Please contact: Trond Riise
Principal Coordinator
Nina Grytten Torkildsen
E-mail: nina.grytten@helse-bergen.no
Phone: +47 55 97 55 03
